Acute coronary microvascular dysfunction
ICD-10 I24.81 is a billable code used to indicate a diagnosis of acute coronary microvascular dysfunction.
Acute coronary microvascular dysfunction (CMD) is a condition characterized by impaired function of the small blood vessels in the heart, leading to inadequate blood flow and oxygen delivery to the myocardium despite normal coronary artery anatomy. Clinically, patients may present with chest pain, shortness of breath, and fatigue, often without the typical signs of obstructive coronary artery disease. The anatomy involved includes the coronary microvasculature, which plays a crucial role in regulating myocardial blood flow. Disease progression can vary; some patients may experience recurrent episodes of angina, while others may develop heart failure or other complications over time. Diagnostic considerations include the use of advanced imaging techniques such as cardiac MRI, PET scans, and invasive coronary function tests to assess microvascular function. The diagnosis is often challenging due to the absence of significant findings on standard coronary angiography, necessitating a high index of suspicion and thorough evaluation of symptoms and risk factors.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I24.81 specifically covers acute coronary microvascular dysfunction, which may include conditions such as microvascular angina and other forms of ischemic heart disease that do not involve significant coronary artery obstruction.
I24.81 should be used when there is evidence of acute coronary microvascular dysfunction without significant obstructive coronary artery disease, particularly when patients present with symptoms of angina and normal coronary angiography.
Documentation should include clinical symptoms, results from non-invasive tests, and any imaging studies that support the diagnosis of microvascular dysfunction. Detailed notes on patient history and risk factors are also essential.
